Loading company…
Progentix Orthobiology BV develops synthetic bone substitutes for orthopedic surgery aimed at bone regeneration and repair.
Progentix Orthobiology BV is based in the Netherlands and develops synthetic bone substitutes intended to improve healing in orthopedic surgery. It sells products to hospitals and surgical centers, often under long-term and bulk purchase agreements. NuVasive, Inc. acquired the company in January 2009 for USD 15 million. Its listed stage is Series A.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in